Mr. Jon A. Kleu is Vice President of Sales for Syneos Health (Nasdaq:SYNH), a fully integrated biopharmaceutical solutions provider, specializing in Contract Research Organization (CRO) and Contract Commercial Organization (CCO) solutions for the pharma sector. Mr. Kleu has built and led commercial operations for many leading biopharmaceutical companies including: J&J, & Pfizer and has co-promoted brands with Eli Lilly & Forest Labs serving on the joint senior leadership team. Mr. Kleu has also organized and launched a number of pre-revenue, U.S. Pharma, start-up companies in variety of disease states providing a full suite of commercial solutions. Prior to Syneos Health, Mr. Kleu worked with The Upjohn Company and Daiichi Sankyo, a Japanese pharmaceutical company. While at Daiichi Sankyo, he was part of the inaugural management team charged with building its’ first U.S. commercial presence. Daiichi Sankyo went from a pre-revenue initiative to U.S. sales annualizing over $3B. Mr. Kleu held several senior leadership positions with Daiichi Sankyo including VP of Sales. Mr. Kleu is a graduate of The University of North Carolina at Greensboro with a major in Business Administration and a concentration in Marketing.